Table 2.
Primary outcomes at endline
| Intervention facilities | Control facilities | Absolute percentage point difference (95% CI) | OR (95% CI) | p value | |
|---|---|---|---|---|---|
| IPC compliance* | 8181/14 366 (56·9%) | 8336/15 242 (54·7%) | 2·2% (−0·2 to 4·7) | 1·10 (0·99 to 1·21) | 0·07 |
| Hand hygiene compliance | 361/4201 (8·6%) | 295/4454 (6·6%) | 1·1% (−0·7 to 2·8) | 1·35 (0·84 to 2·17) | 0·23 |
| Glove use compliance | 2539/3369 (75·4%) | 2576/3539 (72·8%) | 3·5% (−2·7 to 9·8) | 1·22 (0·86 to 1·73) | 0·27 |
| Injection and blood draw compliance | 4114/4228 (97·3%) | 4306/4515 (95·4%) | 0·7% (−0·2 to 1·6) | 1·61 (0·89 to 2·92) | 0·14 |
| Disinfection compliance | 16/416 (3·8%) | 24/426 (5·6%) | 0·1% (−1·6% to 1·7) | 1·07 (0·28 to 4·06) | 0·93 |
| Waste segregation compliance | 1183/2152 (55·0%) | 1196/2308 (51·8%) | 4·2% (−2·4 to 10·8) | 1·19 (0·90 to 1·57) | 0·22 |
| Overall correct case management of standardised patients† | 120/444 (27·0%) | 136/465 (29·2%) | −2·8% (−8·6 to 3·1) | 0·87 (0·65 to 1·17) | 0·36 |
| Asthma | 7/111 (6·3%) | 6/116 (5·2%) | 1·2% (−5·2 to 7·6) | 1·23 (0·42 to 3·55) | 0·71 |
| Non-malarial febrile illness | 79/111 (71·2%) | 85/117 (72·6%) | −1·9% (−13·8 to 10·0) | 0·91 (0·50 to 1·64) | 0·75 |
| Tuberculosis | 23/111 (20·7%) | 33/116 (28·4%) | −9·0% (−20·0 to 2·1) | 0·60 (0·32 to 1·13) | 0·12 |
| Upper respiratory tract infection | 11/111 (9·9%) | 12/116 (10·3%) | −1·1% (−9·3 to 7·1) | 0·89 (0·38 to 2·08) | 0·80 |
Data are n/N (%), unless otherwise specified. For standardised patients, the denominator in the control group varies across cases because one facility received two standardised patients with non-malarial febrile illness. IPC=infection prevention and control practices. OR=odds ratio.
*
Assessed in 106 facilities in the intervention group and 114 facilities in the control group.
†
Assessed in 111 facilities in the intervention group and 116 facilities in the control group.